Close Menu
    What's Hot

    Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

    September 1, 2026

    Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

    September 1, 2026

    New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

    August 27, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Pacific Life Re Completes Third Asset-Intensive Flow Reinsurance Transaction in Japan

      August 19, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

      September 1, 2026

      Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

      September 1, 2026

      Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

      August 26, 2026

      New Stress Test Shows UK Bulk Purchase Annuity Insurers on Solid Ground

      August 26, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp

      August 26, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Memory Lane Cakes Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Utmost Life and Pensions

      September 1, 2026

      Wood Pension Plan Completes Bulk Purchase Annuity Buy-In With L&G

      September 1, 2026

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

      August 26, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Anna Bailey, Chestnut Capital Management

    Secondary Life Markets March 15, 2024By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    Like most asset classes in the alternative credit market, the life settlement industry has had an interesting few years as macroeconomic changes have impacted fundraising and deal flow. Greg Winterton spoke to Anna Bailey, Managing Partner at asset manager Chestnut Capital Management, to get her thoughts on the current state of the space. 

    GW: Anna, let’s start with something general. What’s your view of the impact of the macroeconomic environment of the past few years on the life settlement market – on both fundraising and deal flow? 

    AB: The market is still steadily growing – not quite the way I think most participants in the market had anticipated, but there is growth year over year. In terms of deal flow, the main observation is that it has become a buyers’ market again and yields are going up because of the higher interest rate regime. Also, fund managers seem to be holding on to cash as the impact of rising rates makes it more difficult to get lending that makes sense – and they can still achieve the yields they have promised investors. With fundraising, I see more pension funds entering the market – despite the better yields on liquid credit, investors are increasingly interested in alternatives that provide higher yields. 

    GW: You penned a guest article for Life Risk News in June last year that discussed the rise in activity in smaller face value policies. Is that something that you’re still seeing, and does it still represent a medium to long term opportunity? 

    AB: Yes, this is a trend we are still seeing and some fund managers who traditionally purchased only large face are widening their parameters and buying policies with less than $1m in net death benefit (NDB). But I don’t know that the market will support any policies with an NDB of less than $100k though because the cost economics just don’t work.  

    GW: Related to the previous question – what’s your view on the increasing influence of the direct-to-consumer channel in the secondary market? Does where the policy comes from have much of an impact on your portfolio construction? 

    AB: I think the direct-to-consumer models are continuing to grow and I appreciate the education aspect of it. There are still many consumers who don’t know that they can sell their life insurance policy. With regards to portfolio construction, it doesn’t much matter whether the deal flow comes from the direct to consumer channel or the intermediated channel. What’s most important is that the origination is done well, and that it’s compliant – no cutting corners – and the insureds are cooperative. 

    GW: Many in the life settlement market comment on what they perceive as an awareness challenge among seniors. But from your perspective as an asset manager, what about the awareness at the end investor level? Is that improving – or not? 

    AB: I think investor awareness is growing. That’s a combination of an increased appetite for alternatives generally, as I mentioned earlier, which has led investors to our space as one option that they might consider, but also a greater awareness of life settlements more generally. I definitely don’t think that we are considered the ‘Wild West’ any longer but that doesn’t mean that there aren’t challenges that we face, but those challenges competition-based, as there are many different types of alternative investments available now. But I also think that speaks to the maturity of our industry; we’re often a serious consideration for an allocation now and a mature asset class should expect competitive pressures. 

    GW: Lastly, Anna, assume that there are investors reading this that are less or unfamiliar with the life settlement asset class. What’s your number one recommendation when it comes to the due diligence that they conduct on asset managers? 

    AB: My main recommendation would be to take as much time as you can to understand the nuances of the underlying asset and the specific drivers of return of it because they’re not the same as many other financial assets. For example, mortality, which is one of the fundamental pillars of our market doesn’t shift daily – sometimes, it’s not even yearly. Having a good grasp on that is key; success in our market is a marathon, not a sprint. 

    Anna Bailey is Managing Partner at Chestnut Capital Management 

    2024 - March Life Settlements Longevity Risk Q&A Volume 3 Issue 3 - March 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

    August 26, 2026By Mark McCord
    Litigation

    Litigation Update: Wells Fargo Bank, N.A. v. Ameritas Life Insurance Corp

    August 26, 2026By Greg Winterton

    Q&A: Mitchell Schepps, Senior Managing Director, Aon

    August 26, 2026By Greg Winterton

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.